Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | MMP9 | P14780 | 1/20 | 0.70 |
| ▸ | AANAT | Q16613 | 1/20 | 0.70 |
| ▸ | NPC1 | O15118 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 1/20 | 0.70 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.68 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.68 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nb-Acetyltryptamine SCHEMBL29669230 | 0.98 | MEN1 (0.97) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL4704852 | 0.90 | MEN1 (0.82) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL13609793 | 0.87 | MEN1 (0.77) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL6394942 | 0.86 | MEN1 (0.76) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL761155 | 0.85 | MTNR1A (0.76) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL20927525 | 0.85 | MEN1 (0.74) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL31114206 | 0.85 | MTNR1A (0.76) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL761706 | 0.85 | MEN1 (0.75) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL5841251 | 0.85 | MEN1 (0.74) | MEN1KMT2ACYP1A2BLMLMNA | |
| SCHEMBL627038 | 0.85 | MEN1 (0.74) | MEN1KMT2ACYP1A2BLMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595497-B2 | Processes for the production of tryptamines | COMPASS PATHFINDER LIMITED (GB) | 2026-04-07 | — | — | US | claimed |
| CN-118791419-A | N-acetyltryptamine compound, composition and application | 南华大学 | 2024-10-18 | — | — | CN | claimed |
| CN-117304090-A | Amide compounds with plant regulation activity, and preparation and application thereof | 中国科学院兰州化学物理研究所 | 2023-12-29 | — | — | CN | claimed |
| CN-116904348-A | Streptomyces sp.P-10 marine Streptomyces and application thereof | 厦门大学 | 2023-10-20 | — | — | CN | claimed |
| US-20210108238-A1 | PROCESSES FOR THE PRODUCTION OF TRYPTAMINES | HERCULES CAPITAL, INC. | 2021-04-15 | — | — | US | claimed |
| CN-112105734-A | Method for producing tryptamine | 新图集生物技术有限责任公司 | 2020-12-18 | — | — | CN | claimed |
| EP-3039068-B1 | MOISTURE CURABLE COMPOUND WITH AMINO ACIDS | MOMENTIVE PERFORMANCE MAT INC (US) | 2020-12-16 | — | — | EP | claimed |
| US-20200046693-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ZELLWEGER SPECTRUM DISORDER | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-02-13 | — | — | US | claimed |
| US-9914809-B2 | Moisture curable composition with amino acids | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2018-03-13 | — | — | US | claimed |
| US-20160200880-A1 | MOISTURE CURABLE COMPOSITION WITH AMINO ACIDS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-07-14 | — | — | US | claimed |
| WO-2000040217-B1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-10-05 | — | — | WO | claimed |
| WO-2000040217-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-07-13 | — | — | WO | claimed |
| WO-1994013686-A1 | GLYCOSYL PHOSPHOTRIESTER DERIVATIVES AND THEIR UTILIZATION FOR THE CENTRAL NERVOUS SYSTEM | INSTITUT PASTEUR (FR) | 1994-06-23 | — | — | WO | claimed |
| EP-0246910-B1 | Coated veterinary implants | HOECHST VETERINAER GMBH (DE) | 1994-03-16 | — | — | EP | claimed |
| US-5283343-A | Melatonin antagonists | WHITBY RESEARCH, INC. (US) | 1994-02-01 | — | — | US | claimed |
| EP-0375726-A4 | MELATONIN ANALOGUES | — | 1991-01-30 | — | — | EP | claimed |
| EP-0375726-A1 | MELATONIN ANALOGUES | Whitby Research Incorporated (US) | 1990-07-04 | — | — | EP | claimed |
| US-4882137-A | MELATONIN | GENE LINK AUSTRALIA LIMITED (AU) | 1989-11-21 | — | — | US | claimed |
| WO-1989001472-A1 | MELATONIN ANALOGUES | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1989-02-23 | — | — | WO | claimed |
| EP-0246910-A2 | Coated veterinary implants | Hoechst Veterinär GmbH (DE) | 1987-11-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595497-B2 | Processes for the production of tryptamines | INMT, TPH1, TPH2 | MEN1 2840/4885KMT2A 1817/4885CYP1A2 313/4885 |
| US-20200046693-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ZELLWEGER SPECTRUM DISORDER | HSD17B4, CYP27A1, OAT | MEN1 3163/4885KMT2A 1938/4885CYP1A2 2458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.